🔗 Permalink

Inventor profile of:

Harry SOKOL

City:

Paris

Country:

France

Published Applications:

Last publication date:

2025-12-04

Top Assignees for applications by Harry SOKOL

The entities that hold a legal rights for patent applications filed by inventor SOKOL Harry:

Assistance Publique-Hopitaux De Paris 3 Paris, France
INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE (INRA) 3 Paris, France
INSTITUT NATIONAL DE RECHERCHE POUR L'AGRICULTURE, L'ALIMENTATION ET L'ENVIRONNEMENT 2 Paris, France
Institut National de la Sante et de la Recherche Medicale 2 Paris, France
SORBONNE UNIVERSITÉ 2 Paris, France
Institut National De La Sante Et De La Recherche Medicale (INSERM) 2 Paris, France
ECOLE D'INGENIEURS DE PURPAN 1 Toulous, France
ECOLE D'INGENIEURS DE PURPAN 1 Toulouse, France
ASSISTANCE PUBLIQUE -HÔPITAUX DE PARIS (APHP) 1 Paris, France
UNIVERSITE D'ANGERS 1 Angers, France
ASSISTANCE PUBLIQUE-HOPITAUX DE PARIS (APHP) 1 Paris, France
Centre National de la Recherche Scientifique (CNRS 1 Paris, France
UNIVERSITÉ PIERRE ET MARIE CURIE (PARIS 6) 1 Paris, France
ASSISTANCE PUBLIQUE-HÔPITAUX DE PARIS 1 Paris, France
INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE (INRA) 1 Paris Cedex 7, France
UNIVERSITE PIERRE ET MARIE CURIE (PARIS 6) 1 Paris, France
INSERM (INSTITUTE NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MEDICALE) 1 Paris, France
INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE 1 Paris, France
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE 1 PARIS, France
UNIVERSITE PIERRE ET MARIE CURIE (PARIS 6) 1 Paris Cedex 05, France
UNIVERSITE DE NANTES 1 Nantes, France
SORBONNE UNIVERSITE 1 Paris, France

Recent patent applications by SOKOL Harry

Harry SOKOL from Paris, FR has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-12-04

US20250367269A1

Human necessities

KYNURENINE AMINOTRANSFERASE AND PRODUCTS THEREOF FOR THE TREATMENT OF ARTHRITIC DISEASES

#2 | 2024-12-12

US20240408183A1

Human necessities

KYNURENINE AMINOTRANSFERASE AND PRODUCTS THEREOF FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASES

#3 | 2024-12-12

US20240408150A1

Human necessities

ASSOCIATION OF A FAECALIBACTERIUM PRAUSNITZII STRAIN AND ANTI-PD-1, ANTI-PD-L1 OR ANTI-CTLA-4 ANTIBODIES FOR THE TREATMENT OF CANCER

#4 | 2023-03-30

US20230095683A1

Human necessities

COPROCOCCUS BACTERIA FOR USE IN THE TREATMENT OF METABOLIC SYNDROME AND INFLAMMATORY BOWEL DISEASES

#5 | 2023-02-02

US20230036163A1

Human necessities

ASSOCIATION OF FAECALIBACTERIUM PRAUSNITZII STRAIN CNCM I-4573 WITH PENTASA® FOR THE TREATMENT AND PREVENTION OF GASTROINTESTINAL INFLAMMATION

#6 | 2022-05-12

US20220143143A1

Human necessities

USE OF ACTIVATORS OF THE ARYL HYDROCARBON RECEPTOR FOR TREATING GLUTEN-INDUCED GASTROINTESTINAL DISEASES

#7 | 2021-07-15

US20210215676A1

Physics

DIAGNOSIS, PROGNOSIS AND TREATMENT OF A DISEASE RELATED TO A DECREASE OF F. PRAUSNITZII

#8 | 2021-01-07

US20210000889A1

Human necessities

METHODS FOR PROGNOSING AND TREATING METABOLIC DISEASES

#9 | 2020-10-08

US20200316138A1

Human necessities

strains for treating and preventing gastrointestinal pain

#10 | 2020-06-18

US20200188450A1

Human necessities

FECAL MICROBIOTA FOR TREATING PATIENTS UNDERGOING A HEMATOPOIETIC STEM CELL TRANSPLANT

#11 | 2020-05-21

US20200155622A1

Human necessities

COMPOSITIONS AND METHODS FOR DECREASING A POPULATION OF BILOPHILA WADSWORTHIA OR INHIBITING THE GROWTH THEREOF

#12 | 2019-12-19

US20190381115A1

Human necessities

FAECALIBACTERIUM PRAUSNITZII STRAINS FOR TREATING AND PREVENTING GASTROINTESTINAL PAIN

#13 | 2019-09-19

US20190282638A1

Human necessities

Use of AhR agonist for the preventive or curative treatment of metabolic syndrome and the associated disorders

#14 | 2019-01-31

US20190030089A1

Human necessities

strain CNCM 1-4573 for the treatment and prevention of gastrointestinal inflammation

#15 | 2018-09-06

US20180250350A1

Human necessities

Pharmaceutical compositions for preventing or treating inflammatory bowel diseases

#16 | 2018-04-05

US20180092949A1

Human necessities

PREVENTION OR TREATMENT OF AN INFECTION BY BACTEROIDES THETAIOTAOMICRON

#17 | 2018-03-29

US20180085429A1

Human necessities

Anti-inflammatory peptides and methods for treating inflammatory diseases

#18 | 2015-11-26

US20150335705A1

Human necessities

ANTI-INFLAMMATORY PEPTIDES

InventorID:

1366072 ⎘